Life Science Company News

Reset
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Kiniksa Pharmaceuticals Corp.

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Madrigal Pharmaceuticals, Inc.

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Annexon, Inc. | Annexin Pharmaceuticals AB (publ)

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  ClearPoint Neuro, Inc.

Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Connect Biopharma

Kamari Pharma Announces Abstracts Accepted for Presentation at the 81st Annual Meeting of the Society for Investigative Dermatology

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Kamari Pharma

IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  IN8bio Inc.

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Chimerix, Inc.

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Intra-Cellular Therapies, Inc.

Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Ultimovacs ASA

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  TScan Therapeutics, Inc.

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  PaxMedica, Inc.

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Globus Medical Inc.

HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Hookipa Pharma Inc.

CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  CVRx, Inc.

INVO Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  INVO Bioscience, Inc.

Panbela Announces Transfer to OTCQB Market

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Panbela Therapeutics, Inc.

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Alvotech

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Alvotech

Renowned Alzheimer's Neurologist Dale Bredesen, MD, Joins Pacific Neuroscience Institute

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »